about
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibioticIn vitro investigation of BK-218, a new oral and parenteral cephalosporin.Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disksAntimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.Comparison of pharmacological and antimicrobial properties of cefadroxil and cephalexin.Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout miceComparison of cefadroxil and cephalothin disk susceptibility test results.Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinIn vivo absorption and disposition of cefadroxil after escalating oral doses in wild-type and PepT1 knockout mice.In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibioticsTherapeutic efficacy of cefadroxil and cephalexin for pneumonia in a rat test model.In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolitesPharmacokinetics of cefadroxil after oral administration in humans.Clinical pharmacology of cefadroxil in infants and children.Cefadroxil monohydrate versus erythromycin in paediatric patients.Clinical experience with cefadroxil in upper and lower respiratory tract infections.An overview of results of world-wide clinical trials with cefadroxil.Cefadroxil in the horse: pharmacokinetics and in vitro antibacterial activity.Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study.
P2860
Q34711495-D5A246F4-5E50-493C-9491-EAAFE072B4A1Q35248808-08C988A2-0121-43B5-8379-5759B8AC0F10Q35564509-A47416F7-7FEF-4921-A9E0-ED5042B4BD7AQ35649259-4385BE7F-66F0-43ED-B8C4-34DACB0127FAQ35654046-F59034B6-0687-420F-9B1C-A7D3D0143BF5Q36459896-AD54A214-04C8-45C2-A018-AA05F3633475Q36464836-67110EE9-21A1-4FE0-97EA-E5A92ABC1DAEQ37093326-9929AEBB-31AE-4CFC-8B07-F9BFB20EC030Q37176214-A6D0B6E2-447D-4F42-8CC0-24DBF277C590Q37222684-A0A5AC8E-10B2-4ECB-BE8A-EC6AD635949EQ37351275-635BDD7F-B083-43F2-BBFE-5787685C13FFQ39828400-4C0B42EC-35D5-49FF-A3AC-0CFADC6DA400Q39828423-0A39BE4F-9821-49D6-8793-B44310E7D8E8Q39834649-6C5F6F02-CA38-429E-9B50-B55CF5070168Q39851267-36BE03F3-CD9B-409C-841B-4336AD50C165Q39856524-E8693551-8F00-4BDF-B65D-DFA95C20F716Q40618551-50F29ED7-45EB-4D54-BD89-06A9172F1F39Q40856374-98584259-12AF-4FFC-8C35-C5DB56FFE876Q40933000-94712645-DCF5-446A-BC12-476461D4BB9BQ40965936-497C3D49-FD24-48F5-98C6-CDC90CF37911Q42663562-FCC398A3-48E2-4533-9CBD-DF5156B2028DQ48311838-57692D84-D8FE-462F-ADD2-FB02D38ABFE8
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Cefadroxil, a new broad-spectrum cephalosporin.
@en
type
label
Cefadroxil, a new broad-spectrum cephalosporin.
@en
prefLabel
Cefadroxil, a new broad-spectrum cephalosporin.
@en
P2860
P356
P1476
Cefadroxil, a new broad-spectrum cephalosporin.
@en
P2093
P2860
P304
P356
10.1128/AAC.11.2.324
P407
P577
1977-02-01T00:00:00Z